A Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled, Parallel Group, 3-arm Study Comparing the Efficacy, Tolerability and Safety of 2 Concentrations of NVN1000 Gel and Vehicle Gel Twice Daily in the Treatment of Acne Vulgaris.

Trial Profile

A Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled, Parallel Group, 3-arm Study Comparing the Efficacy, Tolerability and Safety of 2 Concentrations of NVN1000 Gel and Vehicle Gel Twice Daily in the Treatment of Acne Vulgaris.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2015

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Novan Inc
  • Most Recent Events

    • 29 Sep 2015 Results published in a Novan Therapeutics media release.
    • 19 Mar 2014 Additional trial findings are expected in the second quarter of 2014 according to a Novan Therapeutics media release.
    • 19 Mar 2014 Results have been reported in a Novan Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top